StreetAlpha.app
Home › Stocks › IXHL

Incannex Healthcare Inc. (IXHL)

$1.74
▼ −9.84%
LAST CLOSE · NOV 17

Incannex Healthcare develops combination drugs for sleep apnea and anxiety, based in Norwest, New South Wales. It last closed at $1.74 on Nov 17, down 9.84% on the day. IXHL reports earnings on Fri, Feb 12, 2027.

AI Auto Pilots
Is IXHL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$0
−100.0% vs a year ago
Net income
−$14.8M
EPS (diluted)
−$1.19
Free cash flow
−$3.2M
Valuation
Market cap
$21.8M
12.5M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$68.3M
At Sep 30
Shareholder equity
$66.1M
Shares outstanding
12.5M
At Nov 9
Fiscal year endsJune
ExchangeNasdaq
Financials history
FY2024: $12K$12KFY2024FY2025: $86K$86KFY2025FY2026: $0$0FY2026

From IXHL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Feb 12
2027 · Time not announced
Consensus EPS forecast
-$0.48
$10.0M revenue est.
Year-ago EPS
-$0.85
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated IXHL in the past 90 days.
Average 12-month target
No price targets on IXHL in the past 90 days.
Latest rating changes
Alliance Global PartnersInitiated
Jun 8Buy$18
DateFirmActionRatingPrice target
Jun 8Alliance Global PartnersInitiatedBuy$18
Loading…

Technical Analysis

IXHL · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 34% below its 20 day and 65% below its 50 day average. It is 114% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 17), oversold. The nearest support is the 52 week low at $1.72, and the nearest resistance the Pivot at $1.76.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 8.9%/day
Key levels
$14.9152 week high+756.9%
$3.72200 day average+113.8%
$3.09100 day average+77.6%
$2.8750 day average+64.9%
$2.79Swing high (Oct 28)+60.3%
$2.3420 day average+34.5%
$1.81Pivot R1+4.0%
$1.76Pivot+1.1%
$1.74Last close
$1.7252 week low−1.1%
$1.70Pivot S1−2.3%
Indicators
RSI (14)16.71Oversold below 30Oversold
MACD-0.29Below its signal lineBearish
Stochastic3.0Near the bottom of its rangeOversold
ADX (14)49.5Strong downtrend
Williams %R-98.1Oversold below −80, overbought above −20Oversold
CCI (20)-149.7Oversold below −100, overbought above 100Oversold
Rate of change−30.3%Change over 10 sessionsBearish
ATR (14)$0.15Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IXHL

What happened before

See how IXHL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow IXHL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How IXHL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in IXHL in the last 90 days.

Loading…

See today’s whale options flow across the market →

IXHL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●7 buying vs 7 selling
  • ▲Held by funds +0.7 pts
  • ●Funds holding +0
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding16160.0%
In funds' top 1000–
Held by funds4.3%3.6%+0.7 pts
New / increased2 / 57 / 4−36.4%
Reduced / sold out5 / 22 / 12−50.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IXHL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IXHL is in one of them and how their past IXHL trades turned out.

IXHL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IXHL in an article yet. Here's the latest on the wider market.

About Incannex Healthcare

Incannex Healthcare is a drug development company based in Norwest, New South Wales. It is developing combination medicines taken by mouth, along with a treatment that pairs synthetic psilocybin with psychological therapy. Its main development focus is a treatment for obstructive sleep apnea, and a second program targets generalized anxiety disorder. The company is at the clinical trial stage and aims to give patients treatment options where existing care falls short.

Headquarters
Norwest Nsw